Continuous Update Project acknowledgements

Find out about all the people involved in the CUP

Researchers at Imperial College London

CUP peer reviewers

Cancer survivors protocol committee

Secretariat and Executive Team

Researchers at Imperial College London

Researchers at Imperial College London maintain a central database of research papers on diet, nutrition, physical activity and cancer (including cancer survivors). The team, using the methodology of the Second Expert Report, prepares updated systematic literature reviews (SLRs) of the evidence as agreed with the Continuous Update Project (CUP) Secretariat and the Expert Panel. The review and collection of evidence is independent of the Expert Panel’s judgement of the evidence.

Teresa Norat, Principal Investigator

Leila Abar, Research Associate

Louise Abela, Research Associate

Dagfinn Aune, Research Associate

Margarita Cariolou, Research Associate

Doris Chan, Research Associate

Neesha Nanu, Research Associate

Jakub Sobiecki, Research Associate

Darren Greenwood, Statistical Advisor, University of Leeds

CUP peer reviewers

CUP peer reviewers are drawn from a range of appropriate backgrounds and from many different parts of the world. Two peer review stages are built into the process for the SLRs of updated evidence for the CUP – at the initial protocol stage and also when the updated SLRs were submitted in complete form.

Dr Christian Abnet
, National Cancer Institute
, US

Prof Peter Baade, Cancer Council Queensland, Australia

Dr Laura Baglietto, INSERM, France

Dr Franco Berrino, 
Istituto Nazionale dei Tumori
, Italy

Dr Patrick Bradshaw,
 University of California, US

Dr Cristina Bosetti, 
Istituto di Ricerche Farmacologiche "Mario Negri", Italy

Dr Marie-Christine Boutron-Ruault, Gustave Roussy Institute, France

Dr Bas Bueno-de-Mesquita, 
National Institute of Public Health and the Environment (RIVM)
, Netherlands

Dr Ben Cairns, 
University of Oxford
, UK

Ms Yin Cao, Harvard TH Chan School of Public Health, US

Prof İsmail Çelik,
 Hacettepe Üniversitesi
, Turkey

Dr Ock Chun, 
University of Connecticut, 

Dr Francoise Clavel-Chapelon, 
, France

Dr Helen Coleman, Queen's University Belfast, UK

Prof Michael Coory, 
Murdoch Children's Research Institute, 

Dr Brian Cox,
 University of Otago
, New Zealand

Dr Amanda Cross, 
National Cancer Institute, 

Dr Meira Epplein, Vanderbilt University School of Medicine, US

Dr Andrew Flood,
 University of Minnesota
, US
 (until June 2010)

Prof Elizabeth Fontham, Louisiana State University
, New Orleans, US

Dr Silvia Franceschi
, International Agency for Research on Cancer, 

Dr Neal Freedman,
 National Cancer Institute
, US

Dr Lisa Gallicchio, 
Mercy Medical Center, 

Dr Milan Geybels, 
Maastricht University, 

Dr Carlos Gonzalez, 
Catalan Institute of Oncology, 

Dr Darren Greenwood, University of Leeds, UK

Dr Laura Hardie,
 University of Leeds, 

Dr Michelle Harvie
, University of Manchester, UK

Dr Anette Hjartåker, University of Olso, Norway

Dr Farhad Islami,
 Mount Sinai School of Medicine
, US

Dr Paula Jakszyn, 
Instituto Catalan de Oncología
, Spain

Dr Eleanor Kane, 
University of York, 

Dr Ruth Keogh, 
University of Cambridge, 

Prof Tim Key, 
University of Oxford
, UK

Prof Suminori Kono,
 Kyushu University, 

Dr Petra Lahmann,
 University of Bremen, 

Dr Johanna Lampe, Fred Hutchinson Cancer Research Center, US

Dr Susanna Larsson, 
Karolinska Institutet, 

Prof Michael Leitzmann,
 Regensburg University Medical Center
, Germany
 (until October 2012)

Dr Albert Lowenfels, 
New York Medical College
, US

Dr Jay Lubin, 
National Cancer Institute, 

Dr Steven Mark, 
University of Colorado, 

Prof John Mathers, 
University of Newcastle, 

Prof Susan Mayne,
 Yale School of Public Health, 

Prof Marjorie McCullough, 
American Cancer Society, 

Mr Sam McClinton,
 NHS Grampian
, UK   

Dr Katherine McGlynn,
 National Cancer Institute, US

Dr Dominique Michaud,
 Brown University, 

Prof Anthony Miller,
 University of Toronto
, Canada

Dr Dirk Moore, 
University of Medicine and Denistry of New Jersey, 

Prof Liam Murray, 
Queens University, Belfast, 

Dr Christina Nagle
, Queensland Institute for Medical Research
, Australia

Dr Catherine Olsen,
 Queensland Institute for Medical Research
, Australia

Dr Nicola Orsini, 
Karolinska Institutet, 

Dr Yikyung Park, 
National Cancer Institute
, US

Dr Jerry Polesel
, Centro di Riferimento Oncologico, National Cancer Institute, 

Dr Sabina Rinaldi,
 International Agency for Research on Cancer, 

Dr Kim Robien,
 University of Minnesota, 

Dr Cheryl Rock, 
University of California
, US

Dr Matteo Rota, 
Università degli Studi di Milano-Bicocca, 

Dr Sabrina Schlesinger, 
University of Kiel, Germany

Dr Leo Schouten, 
Maastricht University, Netherlands

Dr Jackilen Shannon, Oregon Institute of Occupational Health Sciences, US

Prof Linda Sharp, University of Newcastle, UK

Dr Xiao-Ou Shu,
 Vanderbilt University, US

Dr Meir Stampfer
, Harvard School of Public Health, US

Prof Jonathan Sterne, 
University of Bristol, 

Dr Rachael Stolzenberg-Solomon,
 National Cancer Institute, US

Dr Susan Sturgeon,
 University of Massachusetts, US

Prof Keitaro Tanaka,
 Saga University, 

Dr Sera Tort,
 Cochrane Lung Cancer Group, Spain

Prof Dimitrios Trichopoulos, 
Harvard School of Public Health, US

Dr Shoichiro Tsugane,
 National Cancer Center, 

Dr Cornelia Ulrich,
 Fred Hutchison Cancer Research Centre, US

Mrs Ros Wade, University of York, UK

Dr Penny Webb, 
Queensland Institute for Medical Research
, Australia

Prof Elisabet Weiderpass Vainio, Karolinska Institutet, Sweden

Prof David Whiteman
, Queensland Institute for Medical Research, 

Dr Elisabet Wirfalt
, Lund University, Sweden

Dr Margaret Wright
, University of Illinois, 

Dr Seiichiro Yamamoto,
 National Cancer Center Research Institute, 

Prof Weimin Ye,
 Karolinska Institutet, 

Dr Kelly Yu,
 National Cancer Institute, 

Dr Jian-Min Yuan,
 University of Pittsburgh, 

Prof Maurice Zeegers, 
University of Birmingham, 

Dr Antonella Zucchetto,
 Centro di Riferimento Oncologico,
 National Cancer Institute, 

Cancer survivors protocol committee

Cancer survivors protocol committee, a special committee, chaired by Dr Lawrence Kushi, was convened to provide advice on how the research evidence on cancer survivors could best be captured. With the help of this committee a new protocol was developed which was used to review the evidence on breast cancer survivors. The members of the committee continue their involvement with this work by acting as advisers. You can view the protocol for reviewing the evidence for breast cancer survivors here. The breast cancer survivors report was published in October 2014.

Lawrence Kushi, Chair
, Kaiser Permanente 
Oakland, CA, US

Marie-Christine Boutron-Ruault, 
INSERM, E3N-EPIC Group, Institut Gustave Roussy Villejuif, 

Bas Bueno-de-Mesquita
, National Institute for Public Health and the Environment (RIVM), Netherlands

Josette Chor, 
School of Public Health and Primary Care
, Chinese University of Hong Kong

Wendy Demark-Wahnefried, 
University of Alabama at Birmingham Comprehensive Cancer Center, 

Darren Greenwood,
 University of Leeds, 

Michelle Harvie
, University of Manchester, 

Secretariat & Executive team

The Secretariat is responsible for the day-to-day management of the CUP and reports to World Cancer Research Fund International’s Science Executive Team. The Continuous Update Project (CUP) is managed by World Cancer Research Fund International on behalf of the other charities within our network.


The Secretariat is led by Rachel Thompson, Head of Research Interpretation at World Cancer Research Fund International.


Emily Almond, Research Interpretation Assistant, World Cancer Research Fund International

Isobel Bandurek, Science Programme Manager (Research Interpretation), World Cancer Research Fund International 

Susannah Brown,
 Senior Science Programme Manager (Research Evidence), World Cancer Research Fund International

Mariano Kälfors, CUP Project Manager, World Cancer Research Fund International

Giota Mitrou, Director of Research Funding and Science External Relations, World Cancer Research Fund International

Martin Wiseman, Medical and Scientific Advisor, World Cancer Research Fund International

Executive team

The Secretariat reports to World Cancer Research Fund International’s Science Executive Team.

Kate Allen,
 Executive Director, Science & Public Affairs, World Cancer Research Fund International

Deirdre McGinley-Gieser, 
Senior Vice President for Programs
 and Strategic Planning, American Institute of Cancer Research